SCHEMBL6739468

SCHEMBL6739468

COc1cc(CNc2nc(C)nc(C)c2Cl)cc(Br)c1O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.48
MAPT P10636 5/20 0.48
GAA P10253 4/20 0.48
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
ALOX15 P16050 3/20 0.48
ALOX12 P18054 2/20 0.48
USP2 O75604 1/20 0.48
HSD17B10 Q99714 1/20 0.48
TRPV1 Q8NER1 2/20 0.42
ALOX5 P09917 1/20 0.38
PTGS2 P35354 1/20 0.38
TSHR P16473 1/20 0.38
POLB P06746 2/20 0.37
KDM4E B2RXH2 2/20 0.36
THRB P10828 1/20 0.36
BLM P54132 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
PDE5A O76074 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6739651 0.81 KMT2A (0.47) ALDH1A1MAPTGAAMEN1KMT2A
SCHEMBL6741858 0.79 KMT2A (0.59) ALDH1A1MAPTGAAMEN1KMT2A
SCHEMBL6743539 0.79 CCNB2 (0.47) GAAMEN1KMT2AALOX15ALOX12
SCHEMBL6745666 0.77 MAPT (0.45) ALDH1A1MAPTMEN1KMT2AHSD17B10
SCHEMBL6744001 0.77 CALM1 (0.40) ALDH1A1MAPTMEN1KMT2AHSD17B10
SCHEMBL6744013 0.77 HSD17B10 (0.37) KMT2AHSD17B10
SCHEMBL6742014 0.76 TSHR (0.48) GAAMEN1KMT2ATSHRPOLB
SCHEMBL6740772 0.74 CHRM4 (0.56) TSHRPDE5ASTAT1MAPK1
SCHEMBL6743052 0.72 ESR1 (0.49) ALDH1A1MAPTGAAMEN1KMT2A
SCHEMBL6742318 0.71 MRGPRX1 (0.52) ALDH1A1MAPTGAAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6818642-B2 CAMPYLOBACTER INFECTION TREATMENT ALTANA PHARMA AG (DE) 2004-11-16 US disclosed
US-20040152714-A1 Benzylaminopyrimidines ALTANA PHARMA AG (DE) 2004-08-05 US disclosed
EP-1395594-A1 NEW BENZYLAMINOPYRIMIDINES Byk Gulden Lomberg Chemische Fabrik GmbH (DE) 2004-03-10 EP disclosed
WO-2002094832-A1 NEW BENZYLAMINOPYRIMIDINES ALTANA PHARMA AG (DE) 2002-11-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040152714-A1 Benzylaminopyrimidines DPYD, PGLS, TPMT ALDH1A1 355/4885MAPT 4405/4885GAA 537/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.